Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 21(8)2020 Apr 15.
Article in English | MEDLINE | ID: mdl-32326620

ABSTRACT

The lack of effective Alzheimer's disease treatment is becoming a challenge for researchers and prompts numerous attempts to search for and develop better therapeutic solutions. Compounds that affect several routes of the neurodegeneration cascade leading to the development of disease are of particular interest. An example of such substances is resveratrol and its synthetic and natural derivatives, which have gained popularity in recent years and show promise as a possible new therapeutic option in the approach to Alzheimer's disease treatment. In this article, the state of the art evidence on the role of resveratrol (RSV) in neuroprotection is presented; research results are summarized and the importance of resveratrol and its derivatives in the treatment of Alzheimer's disease are underlined. It also focuses on various modifications of the resveratrol molecule that should be taken into account in the design of future research on drugs against Alzheimer's disease.


Subject(s)
Alzheimer Disease/drug therapy , Blood-Brain Barrier/drug effects , Metabolic Diseases/drug therapy , Neuroprotection/drug effects , Resveratrol/pharmacology , Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Animals , Benzofurans/pharmacology , Blood-Brain Barrier/metabolism , Central Nervous System Diseases/drug therapy , Central Nervous System Diseases/immunology , Central Nervous System Diseases/metabolism , Humans , Inflammation/drug therapy , Inflammation/metabolism , Metabolic Diseases/metabolism , Oxidative Stress/drug effects , Resveratrol/analogs & derivatives , Stilbenes/pharmacology , tau Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...